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Abstract
We report the anaesthetic management of a 48-year-old male patient with Deafness, Onycho-
Osteodystrophy and mental Retardation syndrome, epilepsy and cerebral palsy who had two dental
procedures under anaesthetic care. For the first short examination sedoanalgesia was employed and
the second, longer, procedure was performed under general anaesthesia. His airway management
was moderately difficult and the postoperative period was complicated by partial seizures involving
the upper extremity and a short period of decreased oxygen saturation. The potential anaesthetic
implications of Deafness, Onycho-Osteodystrophy and mental Retardation syndrome are highlighted.
Introduction
D.O.O.R. syndrome (acronym: congenital deafness, ony-
chodystrophy, osteodystrophy and mental retardation)
was first described in 1961 [1] and eventually defined by
Cantwell in 1975 [2]. The syndrome is a rare genetic
disorder characterized by total or partial congenital
bilateral sensorineural hearing loss resulting from anato-
mical malformation of the inner ear or auditory nerve,
malformations of distal parts of fingers or toes [3],
multiple malformations of the nails and mental retarda-
tion of varying degrees. Other features of the syndrome
include craniofacial abnormities, neurological manifesta-
tions including epileptic seizures, optic atrophy and
peripheral polyneuropathy [4,5]. The syndrome is most
likely inherited in an autosomal recessive fashion and the
majority of subjects have increased levels of 2-oxoglutarate
in the plasma and urine [6]. Less than 50 cases have been
reported in the medical literature and no article has been
related to the anaesthetic management of patients with
this syndrome.
Case presentation
A 48-year-old Caucasian man, weighing 108 kg (BMI 38)
(Figure 1) was scheduled for dental treatment under
general anaesthesia. He had been diagnosed with DOOR
syndrome as an infant and had typical features, for
example: malformations of distal phalanges of the fingers
and nails (Figure 2). Other manifestations during child-
hood included epilepsy with frequent grand-mal seizures,
deafness and significantly delayed psychomotor develop-
ment. Aside from features associated with DOOR syn-
drome and obesity, the patient also had left sided cerebral
palsy, recurrent chest infections, asthma, gastroesophageal
reflux and hypertension. It was difficult to elucidate any
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difficulties. There was no cardiac defect or urogenital
abnormities. His medication included carbamazepine,
omeprazole, salbutamol and budesonide. He had no
allergies. At anaesthetic preassessment the only findings
noted were a thyromental distance of 7.5 cm and good
neck mobility. The neck circumference was measured as
40 cm. Further airway assessment, such as the Mallampati
score, was impossible. Basic observations were performed,
including a blood pressure reading of 150/90 mmHg and
a heart rate of 72 bpm. Oxygen saturation on room air was
95%. He was extremely uncooperative, rendering an
awake dental examination unfeasible.A planwas therefore
made to use short sedation for dental assessment
including X-rays and then to administer general anaes-
thesia for definitive treatment. The patient was premedi-
cated with 4 mg of buccal midazolam and sedated with
titrated intravenous midazolam to a total dose of 5 mg
and fentanyl 100 mcg. Depth of sedation was assessed
using entropy monitoring (GE Healthcare, Chalfont St.
Giles, UK). The baseline values of entropy were inside the
normal range - SE 87, RE 98. During intravenous sedation
the levels dropped to 60 (SE) and 75 (RE) which
corresponded with values seen in patients without
learning difficulties. The procedure lasted 25 minutes
and was uneventful. Based on X-ray examination, the
patient was scheduled for multiple extractions and fillings
under general anaesthesia. The patient was fasted for 6 hrs,
and had his usual dose of antiepileptic and inhalers.
Premedication with 4 mg of buccal midazolam was given,
after which a 20 G i.v. cannula was placed and ranitidine
50 mg and metoclopramide 10 mg administered intrave-
nously. We routinely use these drugs in learning disability
patients as the fasting interval may not be adhered to.
Induction was with propofol (2.5 mg.kg
-1) and fentanyl
(1 mcg.kg
-1). After a trial of bag mask ventilation,
atracurium 0.5 mg.kg
-1 was administered. Due to his
specific facial features and short neck a McCoy blade was
used in the first instance. The laryngeal view was a
Cormack and Lehane grade II and the trachea was
intubated at the first attempt with a size 8.0 cuffed RAE
tube and a cotton throat pack was inserted. The difficult
airway trolley was available and our plan ‘B’ involved the
insertion of a laryngeal mask airway. Maintenance of
anaesthesia was with sevoflurane in an air/oxygen mixture.
Further doses of fentanyl were administered for analgesia
to a total dose of 200 mcg. The procedure lasted
100 minutes and included two complicated surgical
extractions and four fillings. The dentist infiltrated local
anaesthetic. The patient was extubated fully awake without
complications. In the recovery ward, twenty minutes after
extubation, he developed mild partial seizures affectinghis
right forearm and hand. At the time of these seizures, the
patient was fully awake, with SpO2 97% on oxygen mask,
and was haemodynamically stable. The seizure activity
lasted 10 minutes and abated spontaneously. Other
postoperative complications included a short period of
decreased saturations and moderate nausea. The patient
was discharged home that same evening, 4 hours post-
procedure. Oral paracetamol was prescribed for post
operative pain relief.
Discussion
Anaesthetic and postoperative care for patients with
learning disabilities can be very challenging for all
members of the operative team. There have been many
reports describing perioperative care of patients with
various genetic syndromes but the majority of them have
been related to paediatric patients. Adult patients with
genetic syndromes and learning disabilities, apart from
specific features associated with the syndrome, present
additional challenges for the anaesthetic team because of
associated medical disease and potential challenging
behaviour against medical staff.
The genetics of DOOR syndrome has been described in
detail elsewhere [2,7]. In the majority of cases reported, an
Figure 1. Facial features of the patient with DOOR
syndrome.
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esis is supported mainly by the work of Rajab et al. [7],
who described a family with four children affected by this
syndrome. However, some cases have appeared to be
inherited in different patterns: autosomal dominant,
pseudodominant or X-linked. Autosomal dominant
inheritance is usually associated with mild to moderate
learning disability only. DOOR syndrome has been also
associated with some biochemical abnormities. Increased
levels of 2-oxoglutarate in the urine have been described
due to decreased activity of 2-oxoglutaratedecarboxylase
(E10) in both fibroblasts and white blood cells [6].
Central nervous system and musculoskeletal system
pathologies are a prominent feature of DOOR syndrome.
They have very important implications for the anaesthe-
siologist involved in the perioperative management of
these patients.
Typical facial features are an important part in the
diagnosis of DOOR syndrome. They include a coarse
face with shortenedbifrontal diameter, broad nasal bridge,
long prominent philtrum, high arched palate with thick
palatine ridges and low set ears. These features may render
nasotracheal intubation impossible and orotracheal intu-
bation difficult. Poor patient co-operation, deafness and
intellectual disability make awake fibre optic intubation
unfeasible. Plans for anticipated difficult airway manage-
ment, including tracheal intubation through a supraglottic
device or use of video-laryngoscope, should be imple-
mented [8]. In patients with no aspiration risk and for
short procedures, a supraglottic airway alone may be an
option for airway management. Appropriate premedica-
tion should be used. We have good experience in the use
of buccally administered midazolam (dose 0.15-0.25
mg.kg
-1) [9]. Epilepsy is a common feature of this
syndrome. Affected individuals usually develop serious
seizures early in their life. The seizures are usually of a
progressive nature, with increasing frequency or severity.
Episodes of status epilepticus are common and the
seizures can occur on a daily basis [4]. With antiepileptic
medication, liver cytochrome P450 systems may be
induced (CYP3A4 is induced by both carbamazepine
and phenytoin). Doses of opioids and benzodiazepines
should, therefore, be properly adjusted
10. Seizure control
and antiepileptic medication should be optimized before
anaesthesia. In our patient, we used sevoflurane as a
volatile agent at concentration of 1 MAC. This approach
may be controversial because other volatile agents like
isoflurane and desflurane have been described to have an
anti-seizure potential. On the other hand, we have good
experience with sevoflurane and this agent is not contra-
indicated in epilepsy. In low concentrations and when
supplemented with benzodiazepines, nitrous oxide and
opioids it has no significant pro-epileptic activity [11].
Other central nervous system abnormities include deaf-
ness, which may be either sensoneurinal congenital or
progressive and optic atrophy leading to blindness [4].
Varying degrees of cerebral palsy may also be present.
Congenital cardiac defects have been found in approxi-
mately 20% of reported cases of DOOR syndrome.
Abnormities include patent ductus arteriosus, atrial and
ventricular septal defects [4,5]. Careful cardiac evaluation,
auscultation, ECG and echocardiography in indicated
patients should be undertaken before general anaesthesia.
Adult patients with DOOR syndrome are very often obese.
The main contributory factor is patient immobility.
Obesity is associated with well-known pathophysiological
consequences; delayed gastric emptying, high metabolic
demand, decreased functional residual capacity of lungs,
cardiovascular pathologies (increased cardiac output,
increased blood volume, hypertrophy of left ventricle,
pulmonary hypertension) and a high incidence of
obstructive sleep apnoea. It is possible that in our patient
some of his associated symptoms, mainly gastroesopha-
geal reflux, asthma and hypertension could have been
related to undiagnosed sleep apnoea. If using the STOP-
BANG questionnaire [12], the patient would have at least
3 or 4 risk points for sleep apnoea.
Figure 2. Onycho-osteodystrophy in DOOR syndrome.
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association with DOOR syndrome. Dental findings
range from hypoplastic enamel to wide spacing,
abnormal size, shape or number of teeth [2]. Genito-
urinary abnormities are variable and may include one-
sided renal agenesis, duplicated kidney, cystic and
dysplastic kidneys, hydroureteronephrosis without
obstruction or frequent urinary tract infections leading
to urosepsis [4,5]. Renal function should be assessed
before general anaesthesia.
Conclusion
DOOR syndrome poses many challenges to the anaes-
thesiologist: it is a multisystem disorder in patients with
moderate to severe intellectual disability and there is a
distinct possibility of a difficult airway. Careful planning
and perioperative management is essential to overcome
these obstacles.
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